
Dr. Chancellor discusses novel regenerative therapy for recurrent SUI
“This is a successfully completed phase 3 trial in regenerative medicine in our field, and there's demonstrated safety and efficacy for women who have failed previous surgery, a very difficult group of patients for all of us,” says Michael B. Chancellor, MD.
In this video, Michael B. Chancellor, MD, discusses the background, findings and takeaways of the study, “An evaluation of women with persistent or recurrent stress urinary incontinence (SUI) following surgery in a double-bling, randomized, controlled trial comparing safety and efficacy of autologous muscle derived cells for urinary sphincter repair (AMDC-USR) with placebo (PBO),” presented at the 2021 American Urological Association Annual Meeting. Chancellor is a professor and director of neurourology at Oakland University, Royal Oak, Michigan.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.


















